ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has announced the composition of its Board of Directors, including Executive, Non-executive, and Independent Non-executive members. The company also disclosed the structure of its three Board committees—Audit, Remuneration, and Nomination—detailing the roles of each director with specific committee chairmanships and memberships.
For further insights into HK:1541 stock, check out TipRanks’ Stock Analysis page.